Analysts’ Viewpoint on Smart Insulin Pens Market Scenario
Smart insulin pens are used to deliver insulin for the treatment of type 1 and type 2 diabetes. These insulin pens have additional features such as memory function, time and dose recorder, and data transfer. Rise in prevalence of the two types of diabetes in children and adults, owing to obesity and changing lifestyle & dietary habits, is a key factor expected to drive the global smart insulin pens market in the next few years. Technological advancements and integration of glucose monitoring and therapeutics for better diabetes management are likely to propel the global smart insulin pen market during the forecast period. Manufacturers of smart insulin pens are regularly launching new products to broaden their revenue streams.
Smart insulin pen is a reusable injector pen that can be connected to a smartphone app, which helps diabetic patients to better manage insulin administration. Most diabetic patients have difficulty calculating their insulin dosage correctly. This can lead to insulin stacking. Adding more insulin while the rest of the insulin is still active in the body from previous doses can lead to hypoglycemia. Smart insulin pen can calculate each dose based on the current blood sugar level, carbohydrate amounts, meal size, active insulin, and settings prescribed by the doctor. It can also deliver accurate half-unit doses; help prevent skipped or missed doses; keep track of the time and amount of each dose; and remind a patient when it is time for the next one. The two types of insulin pen are disposable and reusable. Disposable pens are prefilled with insulin. These can be disposed when the insulin runs out. Reusable pen allows replacement of cartridge when empty. Overall, large number of people prefer insulin pens over syringes. It is easier to carry insulin pens and prepare doses for injection.
In 2022, the American Diabetes Association (ADA) updated its diabetes guidelines. For the first time, the ADA recommended insulin pens instead of vials and syringes. Newer devices, such as smart insulin pens, are likely to play a role in better management of diabetes, which is a chronic disease. A number of technologies have become available to help diabetic patients control their insulin usage over the last decade. Smart insulin pen can help patients adjust insulin doses, monitor blood sugar, and make dosage reminders. The global smart insulin pens market analysis indicates that different smart insulin pens are available based on patient convenience.
Diabetes is a leading cause of death globally. The prevalence of diabetes is increasing in the adult and pediatric population. In November 2018, the American Diabetes Association entered into a partnership with the American Heart Association to increase awareness about cardiovascular diseases caused due to type 2 diabetes.
Diabetes is a leading cause of death in India. The Ministry of Health and Family Welfare (MoHFW) launched mDiabetes, a mobile health initiative for the prevention and care of diabetes, in collaboration with the WHO Country Office for India and other partners. The Division of Diabetes and Translation, a department of the CDC, supports activities and programs that help prevent type 2 diabetes and improve patient health outcomes. In March 2015, NHS and Public Health England launched a National NHS Diabetes Prevention Program. Prevalence of type 2 diabetes has decreased in the U.K. through this program. The National Programme for Prevention and Control of Cancers, Diabetes, Cardiovascular Diseases, and Stroke is arranged by the National Health Mission. The program aims to strengthen the infrastructure, primary healthcare system, and health prevention. Thus, increase in awareness about diabetes is likely to drive the global smart insulin pens market share during the forecast period.
Smart insulin pens offer significant advantages in diabetes management. These pens carry additional features that help record the last dose of insulin. Taking insulin every day through a syringe and needle is quite difficult and stressful. Hence, patients prefer integrated technology. Usage of smartphone and the Internet for record tracking has increased due to advances in the device connectivity technology. Integrated technology helps detect the blood glucose level and calculate the insulin dose. Additionally, it provides a predetermined time interval for insulin administration. Self-collected information by a patient is transferred via smart technological tools and apps to physicians or medical professionals. For instance, InPen insulin pens are connected with smartwatches & armbands and smart apps, which help record physical activity and transfer the data to physicians.
Diabetes is a disease, in which a patient’s blood glucose level increases. Type 1 is insulin-dependent diabetes, while type 2 is non-insulin-dependent. A patient suffering from diabetes finds it quite painful and stressful to self-administer doses of insulin every day. Hence, patients are looking for pain-free, safe, cost-effective, and easy-to-handle novel insulin delivery technologies.
Smart insulin pens carry several advantages over conventional delivery. They provide better flexibility regarding the daily schedule and also improve the quality of life. These insulin pens can deliver accurate dosage of insulin. The memory feature of smart insulin pen can recall the timing and amount of the previous dose. Furthermore, the portable and convenient nature of pens is a key advantage over conventional delivery. Smart insulin pens save time, as they contain a pre-set insulin level and are prefilled. Administration of insulin with pens is time-saving and is highly preferred among children and older adults. These features of smart insulin pens lead to higher patient compliance.
Emerging technologies in smart insulin pens are projected to drive the global smart insulin pens market size during the forecast period. iSenz, an adaptor for smart insulin pens, has a feature to detect the insulin level by scanning. It provides the correct angles for injections in order to optimize the injection sites for diabetes. Easylog is an adaptor for insulin pens connected via the Internet. It provides the right dosage and offers better comfort to the patient for the treatment of chronic diseases such as diabetes. InsulCheck is a cap for insulin pens that contains a sensor to track pen usage and temperature.
In terms of product, the smart insulin pens market has been bifurcated into adaptors for conventional pens and smart insulin pens segments. The adaptors for conventional pens segment accounted for the leading share of the global market in 2021. The trend is anticipated to continue during the forecast period. Rise in prevalence of diabetes in people of all ages across the globe is projected to drive the segment during the forecast period.
Technological advancements such as memory function and accurate dosage administration are anticipated to augment the smart insulin pens segment during the forecast period.
North America accounted for major share of the global market in 2021. The market in the region is driven by the presence of key players and high rate of adoption of technologies. Rise in prevalence of diabetes and new product launches and approval are likely to propel the market in North America. The market in Europe is driven by the increase in prevalence of diabetes. According to the International Diabetes Federation, around 352 million people were at risk of developing type 2 diabetes in Europe in 2017. The smart insulin pens market in Asia Pacific is projected to grow at a rapid pace during the forecast period owing to the increase in geriatric population with diabetes in the region.
The global smart insulin pens market is highly fragmented, with the presence of a large number of players. Key players are expanding their footprint to strengthen their position in the global market. Prominent players operating in the global smart insulin pens market are Novo Nordisk A/S, Sanofi (Sanofi-Aventis US LLC), Eli Lilly and Company, Medtronic plc, Emperra GmbH, Bigfoot Biomedical, Jiangsu Deflu Medical Device Co. Ltd., Diamesco Co. Ltd., and Ypsomed Holding AG.
Each of these players has been profiled in the smart insulin pens market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 31.2 Mn |
|
Market Forecast Value in 2031 |
More than US$ 90.1 Mn |
|
Growth Rate (2022–2031) |
11.2% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, the qualitative analysis includes drivers, restraints, opportunities, key trends, and a parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global smart insulin pens market was valued at US$ 31.2 Mn in 2021
The global smart insulin pens market is projected to reach more than US$ 90.1 Mn by 2031
The global smart insulin pens market grew at a CAGR of 4.0% from 2017 to 2021
The global smart insulin pens market is anticipated to grow at a CAGR of 11.2% from 2022 to 2031
The smart insulin pens segment held around 55% share of the global smart insulin pens market in 2021
Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Medtronic plc, Emperra GmbH, Bigfoot Biomedical, Jiangsu Deflu Medical Device Co. Ltd., Diamesco Co. Ltd., and Ypsomed Holding AG
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Smart Insulin Pens Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Smart Insulin Pens Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Type-I Diabetes Prevalence by region/globally
5.3. Regulatory Scenario by Region/globally
5.4. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Smart Insulin Pens Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Smart Insulin Pens
6.3.2. Adaptors for Conventional Pens
6.4. Market Attractiveness Analysis, by Product
7. Global Smart Insulin Pens Market Analysis and Forecast, by Connectivity Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Connectivity Type, 2017–2031
7.3.1. Bluetooth
7.3.2. USB
7.4. Market Attractiveness Analysis, by Connectivity Type
8. Global Smart Insulin Pens Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Type 1 Diabetes
8.3.2. Type 2 Diabetes
8.4. Market Attractiveness Analysis, by Application
9. Global Smart Insulin Pens Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Distribution Channel, 2017–2031
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Diabetes Clinics/Centers
9.3.4. E-commerce
9.4. Market Attractiveness Analysis, by Distribution Channel
10. Global Smart Insulin Pens Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Smart Insulin Pens Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Smart Insulin Pens
11.2.2. Adaptors for Conventional Pens
11.3. Market Value Forecast, by Connectivity Type, 2017–2031
11.3.1. Bluetooth
11.3.2. USB
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Type 1 Diabetes
11.4.2. Type 2 Diabetes
11.5. Market Value Forecast, by Distribution Channel, 2017–2031
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Diabetes Clinics/Centers
11.5.4. E-commerce
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Connectivity Type
11.7.3. By Application
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Smart Insulin Pens Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Smart Insulin Pens
12.2.2. Adaptors for Conventional Pens
12.3. Market Value Forecast, by Connectivity Type, 2017–2031
12.3.1. Bluetooth
12.3.2. USB
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Type 1 Diabetes
12.4.2. Type 2 Diabetes
12.5. Market Value Forecast, by Distribution Channel, 2017–2031
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Diabetes Clinics/Centers
12.5.4. E-commerce
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Connectivity Type
12.7.3. By Application
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region
13. Asia Pacific Smart Insulin Pens Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Smart Insulin Pens
13.2.2. Adaptors for Conventional Pens
13.3. Market Value Forecast, by Connectivity Type, 2017–2031
13.3.1. Bluetooth
13.3.2. USB
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Type 1 Diabetes
13.4.2. Type 2 Diabetes
13.5. Market Value Forecast, by Distribution Channel, 2017–2031
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Diabetes Clinics/Centers
13.5.4. E-commerce
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Connectivity Type
13.7.3. By Application
13.7.4. By Distribution Channel
13.7.5. By Country/Sub-region
14. Latin America Smart Insulin Pens Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Smart Insulin Pens
14.2.2. Adaptors for Conventional Pens
14.3. Market Value Forecast, by Connectivity Type, 2017–2031
14.3.1. Bluetooth
14.3.2. USB
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Type 1 Diabetes
14.4.2. Type 2 Diabetes
14.5. Market Value Forecast, by Distribution Channel, 2017–2031
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Diabetes Clinics/Centers
14.5.4. E-commerce
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Connectivity Type
14.7.3. By Application
14.7.4. By Distribution Channel
14.7.5. By Country/Sub-region
15. Middle East & Africa Smart Insulin Pens Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2017–2031
15.2.1. Smart Insulin Pens
15.2.2. Adaptors for Conventional Pens
15.3. Market Value Forecast, by Connectivity Type, 2017–2031
15.3.1. Bluetooth
15.3.2. USB
15.4. Market Value Forecast, by Application, 2017–2031
15.4.1. Type 1 Diabetes
15.4.2. Type 2 Diabetes
15.5. Market Value Forecast, by Distribution Channel, 2017–2031
15.5.1. Hospital Pharmacies
15.5.2. Retail Pharmacies
15.5.3. Diabetes Clinics/Centers
15.5.4. E-commerce
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Connectivity Type
15.7.3. By Application
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis, by Company, 2021
16.3. Company Profiles
16.3.1. Novo Nordisk A/S
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Sanofi (Sanofi-Aventis US LLC)
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Eli Lilly and Company
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Medtronic plc
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Emperra GmbH
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Bigfoot Biomedical
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Jiangsu Deflu Medical Device Co. Ltd.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Diamesco Co. Ltd.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Ypsomed Holding AG
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
List of Tables
Table 01: Global Smart Insulin Pens Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Smart Insulin Pens Market Value (US$ Mn) Forecast, by Connectivity Type, 2017–2031
Table 03: Global Smart Insulin Pens Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 04: Global Smart Insulin Pens Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
Table 05: Global Smart Insulin Pens Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 08: North America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Connectivity Type, 2017–2031
Table 09: North America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 10: North America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
Table 12: Europe Smart Insulin Pens Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 13: Europe Smart Insulin Pens Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 14: Europe Smart Insulin Pens Market Value (US$ Mn) Forecast, by Connectivity Type, 2017–2031
Table 15: Europe Smart Insulin Pens Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Europe Smart Insulin Pens Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
Table 17: Asia Pacific Smart Insulin Pens Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 18: Asia Pacific Smart Insulin Pens Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 19: Asia Pacific Smart Insulin Pens Market Value (US$ Mn) Forecast, by Connectivity Type, 2017–2031
Table 20: Asia Pacific Smart Insulin Pens Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 21: Asia Pacific Smart Insulin Pens Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
Table 22: Latin America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 23: Latin America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 24: Latin America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Connectivity Type, 2017–2031
Table 25: Latin America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 26: Latin America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
Table 27: Middle East & Africa Smart Insulin Pens Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 28: Middle East & Africa Smart Insulin Pens Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 29: Middle East & Africa Smart Insulin Pens Market Value (US$ Mn) Forecast, by Connectivity, Type 2017–2031
Table 30: Middle East & Africa Smart Insulin Pens Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 31: Middle East & Africa Smart Insulin Pens Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
List of Figures
Figure 01: Global Smart Insulin Pens Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Smart Insulin Pens Market Value Share, by Product, 2021
Figure 03: Global Smart Insulin Pens Market Value Share, by Connectivity Type, 2021
Figure 04: Global Smart Insulin Pens Market Value Share, by Application, 2021
Figure 05: Global Smart Insulin Pens Market Value Share, by Distribution Channel, 2021
Figure 06: Global Smart Insulin Pens Market, by Product, 2021 and 2031
Figure 07: Global Smart Insulin Pens Market Attractiveness Analysis, by Smart Insulin Pen, 2021–2031
Figure 08: Global Smart Insulin Pens Market Attractiveness Analysis, by Adaptors for Conventional Pens, 2021–2031
Figure 09: Global Smart Insulin Pens Market, by Connectivity Type, 2021 and 2031
Figure 10: Global Smart Insulin Pens Market Attractiveness Analysis, by Connectivity Type, 2021–2031
Figure 11: Global Smart Insulin Pens Market Attractiveness Analysis, by Bluetooth, 2021–2031
Figure 12: Global Smart Insulin Pens Market Attractiveness Analysis, by USB, 2021–2031
Figure 13: Global Smart Insulin Pens Market, by Application, 2021 and 2031
Figure 14: Global Smart Insulin Pens Market Attractiveness Analysis, by Application, 2021–2031
Figure 15: Global Smart Insulin Pens Market (US$ Mn), by Type 1 Diabetes, 2017–2031
Figure 16: Global Smart Insulin Pens Market (US$ Mn), by Type 2 Diabetes, 2017–2031
Figure 17: Global Smart Insulin Pens Market, by Distribution Channel, 2021 and 2031
Figure 18: Global Smart Insulin Pens Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 19: Global Smart Insulin Pens Market (US$ Mn), by Hospital Pharmacies, 2017–2031
Figure 20: Global Smart Insulin Pens Market (US$ Mn), by Online Sales, 2017–2031
Figure 21: Global Smart Insulin Pens Market (US$ Mn), by Retail Pharmacies, 2017–2031
Figure 22: Global Smart Insulin Pens Market (US$ Mn), by Diabetes Clinics/Centers, 2017–2031
Figure 23: Global Smart Insulin Pens Market Value Share Analysis, by Region, 2021 and 2031
Figure 24: Global Smart Insulin Pens Market Attractiveness Analysis, by Region, 2017–2031
Figure 25: North America Smart Insulin Pens Market Value (US$ Mn) Forecast, 2017–2031
Figure 26: North America Smart Insulin Pens Market Value Share Analysis, by Country, 2021 and 2031
Figure 27: North America Smart Insulin Pens Market Attractiveness Analysis, by Country, 2021–2031
Figure 28: North America Smart Insulin Pens Market Value Share Analysis, by Product, 2021 and 2031
Figure 29: North America Smart Insulin Pens Market Attractiveness Analysis, by Product, 2021–2031
Figure 30: North America Smart Insulin Pens Market Value Share Analysis, by Connectivity Type, 2021 and 2031
Figure 31: North America Smart Insulin Pens Market Attractiveness Analysis, by Connectivity Type, 2021–2031
Figure 32: North America Smart Insulin Pens Market Value Share Analysis, by Application, 2021 and 2031
Figure 33: North America Smart Insulin Pens Market Attractiveness Analysis, by Application, 2021–2031
Figure 34: North America Smart Insulin Pens Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 35: North America Smart Insulin Pens Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 36: Europe Smart Insulin Pens Market Value (US$ Mn) Forecast, 2017–2031
Figure 37: Europe Smart Insulin Pens Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 38: Europe Smart Insulin Pens Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 39: Europe Smart Insulin Pens Market Value Share Analysis, by Product, 2021 and 2031
Figure 40: Europe Smart Insulin Pens Market Attractiveness Analysis, by Product, 2021–2031
Figure 41: Europe Smart Insulin Pens Market Value Share Analysis, by Connectivity Type, 2021 and 2031
Figure 42: Europe Smart Insulin Pens Market Attractiveness Analysis, by Connectivity Type, 2021–2031
Figure 43: Europe Smart Insulin Pens Market Value Share Analysis, by Application, 2021 and 2031
Figure 44: Europe Smart Insulin Pens Market Attractiveness Analysis, by Application, 2021–2031
Figure 45: Europe Smart Insulin Pens Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 46: Europe Smart Insulin Pens Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 47: Asia Pacific Smart Insulin Pens Market Value (US$ Mn) Forecast, 2017–2031
Figure 48: Asia Pacific Smart Insulin Pens Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 49: Asia Pacific Smart Insulin Pens Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 50: Asia Pacific Smart Insulin Pens Market Value Share Analysis, by Product, 2021 and 2031
Figure 51: Asia Pacific Smart Insulin Pens Market Attractiveness Analysis, by Product, 2021–2031
Figure 52: Asia Pacific Smart Insulin Pens Market Value Share Analysis, by Connectivity Type, 2021 and 2031
Figure 53: Asia Pacific Smart Insulin Pens Market Attractiveness Analysis, by Connectivity Type, 2021–2031
Figure 54: Asia Pacific Smart Insulin Pens Market Value Share Analysis, by Application, 2021 and 2031
Figure 55: Asia Pacific Smart Insulin Pens Market Attractiveness Analysis, by Application, 2021–2031
Figure 56: Asia Pacific Smart Insulin Pens Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 57: Asia Pacific Smart Insulin Pens Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 58: Latin America Smart Insulin Pens Market Value (US$ Mn) Forecast, 2017–2031
Figure 59: Latin America Smart Insulin Pens Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 60: Latin America Smart Insulin Pens Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 61: Latin America Smart Insulin Pens Market Value Share Analysis, by Product, 2021 and 2031
Figure 62: Latin America Smart Insulin Pens Market Attractiveness Analysis, by Product, 2021–2031
Figure 63: Latin America Smart Insulin Pens Market Value Share Analysis, by Connectivity Type, 2021 and 2031
Figure 64: Latin America Smart Insulin Pens Market Attractiveness Analysis, by Connectivity Type, 2021–2031
Figure 65: Latin America Smart Insulin Pens Market Value Share Analysis, by Application, 2021 and 2031
Figure 66: Latin America Smart Insulin Pens Market Attractiveness Analysis, by Application, 2021–2031
Figure 67: Latin America Smart Insulin Pens Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 68: Latin America Smart Insulin Pens Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 69: Middle East & Africa Smart Insulin Pens Market Value (US$ Mn) Forecast, 2017–2031
Figure 70: Middle East & Africa Smart Insulin Pens Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 71: Middle East & Africa Smart Insulin Pens Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 72: Middle East & Africa Smart Insulin Pens Market Value Share Analysis, by Product, 2021 and 2031
Figure 73: Middle East & Africa Smart Insulin Pens Market Attractiveness Analysis, by Product, 2021–2031
Figure 74: Middle East & Africa Smart Insulin Pens Market Value Share Analysis, by Connectivity Type, 2021 and 2031
Figure 75: Middle East & Africa Smart Insulin Pens Market Attractiveness Analysis, by Connectivity Type, 2021–2031
Figure 76: Middle East & Africa Smart Insulin Pens Market Value Share Analysis, by Application, 2021 and 2031
Figure 77: Middle East & Africa Smart Insulin Pens Market Attractiveness Analysis, by Application, 2021–2031
Figure 78: Middle East & Africa Smart Insulin Pens Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 79: Middle East & Africa Smart Insulin Pens Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Smart Insulin Pens Market
